198 related articles for article (PubMed ID: 22816528)
1. The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study.
O'Malley CD; Shema SJ; Cress RD; Bauer K; Kahn AR; Schymura MJ; Wike JM; Stewart SL
J Womens Health (Larchmt); 2012 Sep; 21(9):887-94. PubMed ID: 22816528
[TBL] [Abstract][Full Text] [Related]
2. Survival of Australian women with invasive epithelial ovarian cancer: a population-based study.
Anuradha S; Webb PM; Blomfield P; Brand AH; Friedlander M; Leung Y; Obermair A; Oehler MK; Quinn M; Steer C; Jordan SJ
Med J Aust; 2014 Sep; 201(5):283-8. PubMed ID: 25163381
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer outcomes: Predictors of early death.
Urban RR; He H; Alfonso R; Hardesty MM; Gray HJ; Goff BA
Gynecol Oncol; 2016 Mar; 140(3):474-80. PubMed ID: 26743531
[TBL] [Abstract][Full Text] [Related]
4. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
Vogel TJ; Goodman MT; Li AJ; Jeon CY
Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
[TBL] [Abstract][Full Text] [Related]
5. Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care study.
Cress RD; Bauer K; O'Malley CD; Kahn AR; Schymura MJ; Wike JM; Stewart SL; Leiserowitz GS
Gynecol Oncol; 2011 Apr; 121(1):94-9. PubMed ID: 21256581
[TBL] [Abstract][Full Text] [Related]
6. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?
Chan JK; Loizzi V; Lin YG; Osann K; Brewster WR; DiSaia PJ
Obstet Gynecol; 2003 Jul; 102(1):156-61. PubMed ID: 12850623
[TBL] [Abstract][Full Text] [Related]
7. Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study.
O'Malley CD; Cress RD; Campleman SL; Leiserowitz GS
Gynecol Oncol; 2003 Dec; 91(3):608-15. PubMed ID: 14675685
[TBL] [Abstract][Full Text] [Related]
8. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
[TBL] [Abstract][Full Text] [Related]
9. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.
Bandera EV; Lee VS; Rodriguez-Rodriguez L; Powell CB; Kushi LH
JAMA Oncol; 2015 Sep; 1(6):737-45. PubMed ID: 26181758
[TBL] [Abstract][Full Text] [Related]
10. High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.
Bristow RE; Chang J; Ziogas A; Randall LM; Anton-Culver H
Gynecol Oncol; 2014 Feb; 132(2):403-10. PubMed ID: 24361578
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective.
Elstrand MB; Sandstad B; Oksefjell H; Davidson B; Tropé CG
Acta Obstet Gynecol Scand; 2012 Mar; 91(3):308-17. PubMed ID: 22050605
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors of epithelial ovarian cancer in young women].
Zhang R; Wu LY; Zhang WH; Li HJ; Li SM; Liu LY
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):264-7. PubMed ID: 12839691
[TBL] [Abstract][Full Text] [Related]
13. Impact of cardiovascular comorbidity on ovarian cancer mortality.
Shinn EH; Lenihan DJ; Urbauer DL; Basen-Engquist KM; Valentine A; Palmero L; Woods ML; Patel P; Nick AM; Shahzad MM; Stone RL; Golden A; Atkinson E; Lutgendorf SK; Sood AK
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2102-9. PubMed ID: 24045927
[TBL] [Abstract][Full Text] [Related]
14. Ten-year relative survival for epithelial ovarian cancer.
Baldwin LA; Huang B; Miller RW; Tucker T; Goodrich ST; Podzielinski I; DeSimone CP; Ueland FR; van Nagell JR; Seamon LG
Obstet Gynecol; 2012 Sep; 120(3):612-8. PubMed ID: 22914471
[TBL] [Abstract][Full Text] [Related]
15. Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer-A National Cancer Database Study.
Leiserowitz GS; Lin JF; Tergas AI; Cliby WA; Bristow RE
Int J Gynecol Cancer; 2017 May; 27(4):675-683. PubMed ID: 28328580
[TBL] [Abstract][Full Text] [Related]
16. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study.
Tetsche MS; Dethlefsen C; Pedersen L; Sorensen HT; Norgaard M
BMC Cancer; 2008 Jan; 8():31. PubMed ID: 18230177
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data.
Polterauer S; Vergote I; Concin N; Braicu I; Chekerov R; Mahner S; Woelber L; Cadron I; Van Gorp T; Zeillinger R; Castillo-Tong DC; Sehouli J
Int J Gynecol Cancer; 2012 Mar; 22(3):380-5. PubMed ID: 22266934
[TBL] [Abstract][Full Text] [Related]
18. The influence of comorbidity on mortality in ovarian cancer patients.
Stålberg K; Svensson T; Lönn S; Kieler H
Gynecol Oncol; 2014 May; 133(2):298-303. PubMed ID: 24582801
[TBL] [Abstract][Full Text] [Related]
19. Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?
Sahin H; Meydanli MM; Sari ME; Yalcin I; Çoban G; Ozkan NT; Cuylan ZF; Erdem B; Gungorduk K; Akbayir Ö; Dede M; Salman MC; Güngör T; Ayhan A
J Ovarian Res; 2018 Mar; 11(1):21. PubMed ID: 29506569
[TBL] [Abstract][Full Text] [Related]
20. Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study.
Wong KH; Mang OW; Au KH; Law SC
Hong Kong Med J; 2012 Dec; 18(6):466-74. PubMed ID: 23223646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
